Human milk fibronectin: identification of fibronectin fragments by transfer of milk proteins from polyarcrylamide gels to nitrocellulose sheets  by Zardi, Luciano et al.
Volume 143, number 1 FEBS LETTERS June 1982 
Human milk fibronectin: identification of fibronectin fragments by transfer 
of milk proteins from polyarcrylamide gels to nitrocellulose sheets 
Luciano Zardi+, Antonia Destree, Enrica Balza+ and Henri Isliker 
Institute de Biochimie, UniversitP de Lausanne, ch. des Boveresses, 1066 Epalinges, Switzerland and + Istituto ScientiJico per 
lo Studio e la Cura dei Tumori, Viale Benedetto XV, IO, 16132 Genova, Italy 
Received 26 April 1982 
Fibronectin Human milk Protein blotting Fibronectin fragments 
1. INTRODUCTION 
The term ‘Iibronectin’ describes a family of 
structural and immunologically related high-Mi, 
glycoproteins that are present in vertebrates in both 
the soluble and insoluble form. The soluble form 
has been observed in various biological fluids in- 
cluding plasma, cerebrospinal, amniotic and sin- 
ovial fluids, urine and seminal plasma [l-6]. The 
insoluble form is present in vertebrate tissue, intra- 
cellularly, and as an extracellular matrix compo- 
nent [7- 121. 
and the cream removed (fat-free milk). Aliquots 
were then respun at 90 000 X g for 30 min to remove 
casein (lactoserum). All samples were analyzed 
within 24 h after drawing. 
Rabbit monospecific and mouse monoclonal 
anti-human plasma fibronectin antibodies were 
prepared as in [2 1,221. 
Although little is known about the function of 
fibronectin in vivo, it has been shown to display 
many interesting features in vitro ([ 13-201 and ref- 
erences therein). The amount of Iibronectin ,pres- 
ent on the surface of transformed or neoplastic 
cells is generally greatly reduced with respect to 
their normal counterparts. Fibronectin promotes 
cell aggregation and cell substratum adhesivness, 
partially restores transformed tibroblasts to a more 
normal phenotype, promotes locomotion of certain 
types of cells and facilitates reticuloendothelial sys- 
tem clearance of particles. 
Here, we report that human milk contains fibro- 
nectin and other components of lower M, which are 
recognized by anti-Iibronectin antibodies. These 
lower M, components are most probably tibronec- 
tin fragments. 
Immunodiffusion analysis was done in 1% agar- 
ose using the double diffusion method 1231. To 
estimate the amount of tibronectin in fat-free milk 
and lactoserum we have used the solid-phase dou- 
ble-antibody radioimmunoassay in [24]. Sodium 
dodecylsulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) was done as in 1251. The transfer of 
protein from SDS-PAGE to nitrocellulose sheets 
and the immunoenzymatic detection of fibronectin 
was performed as in 1261. Heparin-toluidine blue 
staining was used to locate transferred proteins on 
the nitrocellulose sheets [27]. This reversible stain- 
ing procedure gives a pattern similar to that ob- 
tained with Coomassie brilliant blue R250 and the 
same nitrocellulose sheet, after destaining, can be 
used for immunoenzymatic studies (Towbin, per- 
sonal communication). 
3. RESULTS 
2. MATERIALS AND METHODS 
Milk was obtained from 12 healthy women be- 
tween day 2 and 15 following delivery. Samples of 
2 ml each were centrifuged at 10 000 X g for 30 min 
Fat-free milk samples reacted with monospecitic 
rabbit antibodies to human plasma tibronectin in 
Ouchterlony immunodiffusion analysis showing 
immunological identity with human plasma fibro- 
nectin (fig. 1). 
Milk and plasma total protein, resolved by 
SDS-PAGE, were transferred to nitrocellulose 
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Fig.l.Immunodiffusion assay in 1% agarose: (1) Rabbit 
antibodies to human plasma fibronectin; (2) human 
serum diluted l/50; (3,5) two different undiluted fat-free 
milk samples; (4,6) purified human plasma fibronectin. 
2 3 
Table 1 
Concentration of fibronectin in milk from different sub- 
jects 
Sample Days after pg Fibronectin/ 
no. delivery ml milk 
1 11 1.7 
2 2 3.7 
3 4 4.2 
4 7 6.4 
5 8 1.8 
6 3 6.8 
I 9 6.2 
8 4 6.8 
9 3 1.5 
10 3 1.8 
II 7 8.1 
12 6 12.2 
sheets. The fibronectin bands were subsequently 
identified immunoenzymatically. This procedure 
gives information (subunit composition M,-value, 
possible presence of fragments) on antigens in any 
biological fluid avoiding artifacts due to the purifi- 
cation procedure. 
Fig.2A represents a nitrocellulose sheet, on which 
total serum and milk proteins, after separation on a 
10% SDS-PAGE, were transferred and stained by 
the heparin-toluidine procedure. Fig.2B shows the 
same sheet as in fig. 1A after destaining and immuno- 
enzymatic localization of fibronectin as in section 2. 
Human plasma gave the two typical fibronectin 
polypeptide bands in the 220 000 M, region. In the 
case of milk, the same two 220 000 M, fibronectin 
bands were always accompanied by a certain 
Fig.2. Electrophoretic transfer and localization on nitro- 
cellulose sheets of milk and plasma fibronectin. (A) 
Nitrocellulose sheets on which human serum proteins 
(lanes 1,3) and fat-free milk proteins (lane 2) were trans- 
ferred after separation on a 6% SDS-polyacrylamide gel 
electrophoresis. Proteins were stained with the 
heparin-toluidine blue procedure as in section 2. (B) 
The same sheet from A (lanes 2.3) after destaining 
and immunoenzymatic localization of flbronectin as in 
section 2. 
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number of lower M, bands, probably representing 
tibronectin fragments. 
The amount of fibronectin present in the milk 
was measured using the solid phase radioimmuno- 
assay system section 2. Table 1 shows the fibro- 
nectin concentration in 12 different milk samples. A 
variation ranging from 1.7-12.2 pg/ml between the 
different samples was observed. No difference was 
observed for the fibronectin levels in fat-free milk 
and lactoserum where casein had been removed by 
ultracentrifugation. 
4. DISCUSSION 
Here we show that human milk contains tibro- 
nectin which is immunologically identical to plasma 
fibronectin. Using a radioimmunoassay system we 
have estimated that tibronectin concentrations in 
milk range from 1.2-12.7 pg/ml as compared to 
400-500 pg/ml for human plasma. 
In 1281 fibronectin was reported in bovine colos- 
trum but tibronectin in bovine milk was not ob- 
served. In the limited number of samples analyzed 
we did not observe any correlation between tibro- 
nectin concentration and time elapsed (from 
l-12 days) after delivery. We are presently study- 
ing Iibronectin in milk in a larger number of sub- 
jects at different times following delivery. 
The origin of the tibronectin found in milk is 
unknown. It could originate from local synthesis by 
mammary epithelial cells (29,301 or macrophages 
known to be present in milk. Milk tibronectin could 
also originate from filtration of the blood. 
Fractionation by SDS-PAGE of total fat-free 
milk followed by transfer of the protein to nitro- 
cellulose sheets and immunoenzymatic staining 
demonstrated a limited number of fibronectin frag- 
ments which could not be detected in plasma. The 
origin of these fragments is unclear. One hypothesis 
is that milk fibronectin may have a different 
carbohydrate composition with respect to plasma 
fibronectin, making it more sensitive to proteolytic 
enzymes. 
It is not prudent to speculate on the possible 
biological functions of either intact fibronectin or 
fibronectin fragments in milk. Nevertheless, due to 
the many biological activities observed in vitro, we 
can not exclude the possibility that milk fibronectin 
may play an important role in either the develop- 
ment or defense mechanisms of the new-born child. 
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